![Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma]()
Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin LymphomaBröckelmann, Paul J.; Goergen, Helen; Keller, Ulrich; Meissner, Julia; Ordemann, Rainer; Halbsguth, Teresa V.; Sasse, Stephanie; Sökler, Martin; Kerkhoff, Andrea; Mathas, Stephan; Hüttmann, Andreas; Bormann, Matthias; Zimmermann, Andreas; Mettler, Jasmin; Fuchs, Michael; von Tresckow, Bastian; Baues, Christian; Rosenwald, Andreas; Klapper, Wolfram; Kobe, Carsten; Borchmann, Peter; Engert, Andreas · JAMA Oncology · 2020